| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Neurotensin receptor type 2 |
|---|
| Ligand | BDBM50563034 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2081407 (CHEMBL4737198) |
|---|
| Ki | >1.000000±n/a nM |
|---|
| Citation |  Chartier, M; Desgagné, M; Sousbie, M; Côté, J; Longpré, JM; Marsault, E; Sarret, P Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic. J Med Chem64:2110-2124 (2021) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Neurotensin receptor type 2 |
|---|
| Name: | Neurotensin receptor type 2 |
|---|
| Synonyms: | Levocabastine-sensitive neurotensin receptor | NT-R-2 | NTR2 | NTR2 receptor | NTR2_HUMAN | NTSR2 | Neurotensin receptor | Neurotensin receptor 2 | Neurotensin receptor type 2 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 45404.76 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_1281495 |
|---|
| Residue: | 410 |
|---|
| Sequence: | METSSPRPPRPSSNPGLSLDARLGVDTRLWAKVLFTALYALIWALGAAGNALSAHVVLKA
RAGRAGRLRHHVLSLALAGLLLLLVGVPVELYSFVWFHYPWVFGDLGCRGYYFVHELCAY
ATVLSVAGLSAERCLAVCQPLRARSLLTPRRTRWLVALSWAASLGLALPMAVIMGQKHEL
ETADGEPEPASRVCTVLVSRTALQVFIQVNVLVSFVLPLALTAFLNGVTVSHLLALCSQV
PSTSTPGSSTPSRLELLSEEGLLSFIVWKKTFIQGGQVSLVRHKDVRRIRSLQRSVQVLR
AIVVMYVICWLPYHARRLMYCYVPDDAWTDPLYNFYHYFYMVTNTLFYVSSAVTPLLYNA
VSSSFRKLFLEAVSSLCGEHHPMKRLPPKPQSPTLMDTASGFGDPPETRT
|
|
|
|---|
| BDBM50563034 |
|---|
| n/a |
|---|
| Name | BDBM50563034 |
|---|
| Synonyms: | CHEMBL4742223 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C42H66N6O8 |
|---|
| Mol. Mass. | 783.0088 |
|---|
| SMILES | CC[C@H](C)[C@H](NC(=O)[C@@H]1Cc2ccc(O)c(C\C=C\CCCCCCC(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N1)c2)C(=O)N[C@@H](CC(C)C)C(O)=O |r,t:17| |
|---|
| Structure | 
|
|---|
Search and Browse
